STERIS (STE) Stock Overview
Provides infection prevention products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for STE from our risk checks.
STE Community Fair Values
Create NarrativeSee what 8 others think this stock is worth. Follow their fair value or set your own to get alerts.
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$249.08 |
| 52 Week High | US$253.00 |
| 52 Week Low | US$200.98 |
| Beta | 0.95 |
| 1 Month Change | 1.64% |
| 3 Month Change | 3.69% |
| 1 Year Change | 4.20% |
| 3 Year Change | 49.80% |
| 5 Year Change | 44.25% |
| Change since IPO | 11,976.61% |
Recent News & Updates
Calculating The Fair Value Of STERIS plc (NYSE:STE)
Aug 28
Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy
Aug 17Recent updates
Calculating The Fair Value Of STERIS plc (NYSE:STE)
Aug 28Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy
Aug 17STERIS (NYSE:STE) Is Paying Out A Larger Dividend Than Last Year
Aug 07Is There Now An Opportunity In STERIS plc (NYSE:STE)?
Jul 06Is Now The Time To Put STERIS (NYSE:STE) On Your Watchlist?
May 23Is There An Opportunity With STERIS plc's (NYSE:STE) 33% Undervaluation?
May 07Is STERIS (NYSE:STE) A Risky Investment?
Apr 19Risks To Shareholder Returns Are Elevated At These Prices For STERIS plc (NYSE:STE)
Apr 01Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'
Mar 22Is Now An Opportune Moment To Examine STERIS plc (NYSE:STE)?
Feb 06STERIS plc (NYSE:STE) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 19STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Jan 01STERIS plc's (NYSE:STE) Popularity With Investors Is Clear
Dec 14Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'
Nov 18What Does STERIS plc's (NYSE:STE) Share Price Indicate?
Oct 19Is STERIS (NYSE:STE) A Risky Investment?
Oct 01Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16
Robust Revenue Growth And Expanding Margins In The Medical Equipment Sector
Strong start to the fiscal year and gross margin improvements suggest underappreciated growth momentum and potential for expanding net margins.Steris: Q2 Numbers Solidify Buy Thesis
Aug 13Steris: Moving On, Losing Its Teeth
Apr 14Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01Shareholder Returns
| STE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.1% | -1.2% | -0.6% |
| 1Y | 4.2% | -2.3% | 16.8% |
Return vs Industry: STE exceeded the US Medical Equipment industry which returned -2.3% over the past year.
Return vs Market: STE underperformed the US Market which returned 16.8% over the past year.
Price Volatility
| STE volatility | |
|---|---|
| STE Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: STE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: STE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 17,787 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| STE fundamental statistics | |
|---|---|
| Market cap | US$24.53b |
| Earnings (TTM) | US$647.72m |
| Revenue (TTM) | US$5.57b |
Is STE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STE income statement (TTM) | |
|---|---|
| Revenue | US$5.57b |
| Cost of Revenue | US$3.10b |
| Gross Profit | US$2.47b |
| Other Expenses | US$1.82b |
| Earnings | US$647.72m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.58 |
| Gross Margin | 44.38% |
| Net Profit Margin | 11.63% |
| Debt/Equity Ratio | 27.3% |
How did STE perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/28 01:45 |
| End of Day Share Price | 2025/09/26 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
STERIS plc is covered by 26 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Michael Polark | Baird |
| Erin Wilson Wright | BofA Global Research |